Category: Announcements

Q&A at the starting line: The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) study

1) What does COMPASS-ND stand for? COMPASS-ND stands for: COMPrehensive ASSessment of Neurodegeneration and Dementia. What this means is we’re looking broadly at different types of dementia (including Alzheimer’s disease, Frontotemporal, Lewy Body, and Parkinson’s related dementia) and even potential pre-dementia conditions, like Mild Cognitive Impairment and Subjective Cognitive Decline. We’re taking this broad approach…

Chair: The Wilfred and Joyce Posluns Chair in Women’s Brain Health

Funding Organization Canadian Institutes of Health Research Program Name Chair : The Wilfred and Joyce Posluns Chair in Women’s Brain Health (The Wilfred and Joyce Posluns Chair in Women’s Brain Health and Aging) Sponsor(s) CIHR Institutes of Aging (IA), Gender and Health (IGH), and Neurosciences, Mental Health and Addiction (INMHA) in partnership with the Ontario…

JPND: Opportunity for Transnational Working Groups (with bids of up to €50,000 to support activities)

Deadline for proposal submissions: 23:59H C.E.T., March 10, 2016   Summary: The EU Joint Programme, Neurodegenerative Disease Research (JPND) is calling on leading scientists in the field to form working groups. Teams are tasked with establishing ‘best practice’ guidelines and/or methodological frameworks that will address key challenges in brain imaging techniques in NDD.   Timeline:…

Historic Alzheimer’s Funding Increase Signed Into Law, Answering Alzheimer’s Association Call for Action

December 18th, 2015 marked a tremendous step forward in supporting the advancement of dementia research. As of last Friday, an increase of more than $350 million was signed into law by the President of the United States, Barack Obama, bringing the total of Alzheimer’s research at the National Institutes of Health (NIH) to nearly $1 billion per year. This…

CCNA Researcher, Dr. Sandra Black, Appointed to the Order of Canada

“Clinicians and researchers need to work together to better understand the interactions between stroke, vascular disease, and Alzheimer’s disease in order to tackle neurodegeneration. You can’t focus on one disease and think that you’re going to fix the whole problem.” Dr. Sandra Black Neurodegeneration is a kind of battle between two processes: one that slowly…

Alzheimer’s Research UK Launches New Dementia Discovery Fund

Alzheimer’s Research UK, a CCNA Partner Organization, has joined pharmaceutical companies worldwide and the UK government to launch a $100M (USD) Dementia Discovery Fund. The purpose of the new fund, managed by the venture capital firm SV Life Sciences (SVLS), is to support: “… innovative new drug development projects… with the aim of finding new treatments capable of altering the course of diseases such…

Successful First Partners Forum and Science Day in Ottawa for CCNA

The Canadian Consortium on Neurodegeneration in Aging (CCNA) held its first annual Partners Forum and Scientific meeting in Ottawa at the Élisabeth Bruyère Hospital on September 30 and October 1, 2015. These events brought together the best and brightest Canadian researchers in dementia and the partner organizations of the CCNA to discuss the previous year’s…

Funding Opportunity – BrightFocus Foundation: Alzheimer’s Disease Research Program

  The BrightFocus Foundation is inviting submissions to the Alzheimer’s Disease Research (ADR) program.   Grant Type: Standard Award Postdoctoral Fellowship Award   Amount: $300,000 $100,000 Duration: 3 years 2 years Deadline: October 13, 2015 October 13, 2015 Who should apply: researchers who have already generated some amount of preliminary data, but may need to…